Agreed. Insulin is not technically a new drug. So there is no motivation for the FDA to risk approving something is that is not safe. The billions spent on Afrezza can testify to that. Besides, FDA is in the pocket of big pharma, it won't approve new competitions for those who bribe them either. Al better signs up with a big pharma before the next go around.